CymitQuimica logo

BGC0222

Ref. TM-T203374

CymitQuimica logo
Targetmol

Product Information

Name:BGC0222
Brand:Targetmol
Description:BGC0222 is a novel Irinotecan prodrug. As a PEG-cRGD conjugated derivative of Irinotecan, BGC0222 enables the slow and steady release of Irinotecan. It binds to the αVβ3 target with an IC50 of 4.25 μM and has an IC50 of 58.7 μM for αVβ5. BGC0222 can induce angiogenesis and demonstrates significant antitumor activity in various tumors.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:26927.36
Formula:C1241H2276N64O552
Color/Form:Solid

Technical inquiry about: BGC0222

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.